Start with the injection concern
The Food and Drug Administration, known as FDA, regulates medicines in the US. As of September 2026, FDA warns that injected GHK-Cu could make the body’s defence system react against it. FDA’s warning about the body reacting to an injection describes a possible problem, rather than a reported case in a person.
Understand what could trigger that reaction
FDA links this concern to possible clumps of peptide and unwanted material related to the peptide. A peptide is a short linked chain made from the building blocks of proteins.
Ask about the gaps
FDA says there is little information from studies or other reports about people receiving GHK-Cu injections to judge the harms. Small studies of skin products cannot show how often rare harms occur.
Bring personal questions
Ask about your medicines, pregnancy plans and any condition involving copper. Ask what information the health professional has for your exact situation.
There is no reviewed GHK-Cu information sheet
As of September 2026, GHK-Cu lacks an FDA-reviewed label describing its effects on other medicines or what happens during pregnancy.
A label means the official information sheet for a medicine.
Wilson disease is a condition in which the body holds too much copper.
A September 2026 search of PubMed, one searchable collection of published medical papers, found no GHK-Cu study in people with Wilson disease.
That search checked one collection, not every study that may exist. If you have Wilson disease, ask the doctor what this gap means for your care.
A note on the sources
Read FDA’s own entry for injected GHK-Cu.
FDA entry for injectable GHK-CuRead the explanation of how copper builds up.
MedlinePlus explanation of Wilson diseaseRead the emergency section.
MedlinePlus on severe allergic reactionsThe way an offer is presented also deserves attention.
Read the offer checklist